Human genetics society of australasia position statement: Population-based carrier screening for cystic fibrosis

Twin Research and Human Genetics

Volumn 17, Issue 6, 2014, Pages 578-583

  Delatycki, Martin B ^a,b   Burke, Jo ^c   Christie, Louise ^d   Collins, Felicity ^e   Gabbett, Michael ^f   George, Peter ^g   Haan, Eric ^h   Ioannou, Liane ^b,i   Martin, Nicole ^j   McKenzie, Fiona ^k   O'Leary, Peter ^l   Scoble Williams, Nicole ^m   Turner, Gillian ⁿ   Massie, John ^b,o  

^a AUSTIN HEALTH   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c Tasmanian Clinical Genetics Services   (Australia)

^d Hunter Genetics   (Australia)

^e CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g UNIVERSITY OF OTAGO   (New Zealand)

^h UNIVERSITY OF ADELAIDE   (Australia)

ⁱ MONASH UNIVERSITY   (Australia)

^j Queensland Fertility Group   (Australia)

^k Genetic Services of Western Australia   (Australia)

^l CURTIN UNIVERSITY   (Australia)

^m IVFAustralia   (Australia)

ⁿ UNIVERSITY OF NEWCASTLE   (Australia)

^o ROYAL CHILDREN'S HOSPITAL   (Australia)

more..

Author keywords

carrier; carrier testing; cystic fibrosis; genetic counselling; heterozygote

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

CYSTIC FIBROSIS; GENETICS; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMAN; MUTATION; PRACTICE GUIDELINE; TWINS;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASES IN TWINS; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; MUTATION;

EID: 84914167352     PISSN: 18324274     EISSN: 18392628     Source Type: Journal    
DOI: 10.1017/thg.2014.65     Document Type: Review

References (13)

1. American College of Obstetricians and Gynecologists Committee on Genetics. (2011). ACOG committee opinion no. 486: Update on carrier screening for cystic fibrosis. Obstetrics and Gynecology, 117, 1028-1031.
2. Diso, D., Anile, M., Patella, M., Pecoraro, Y., Rendina, E. A., Carillo, C.,.. Venuta, F. (2013). Lung transplantation for cystic fibrosis: Outcome of 101 single-center consecutive patients. Transplantation Proceedings, 45, 346-348.
3. Grody, W. W., Thompson, B. H., Gregg, A. R., Bean, L. H., Monaghan, K. G., Schneider, A.,.. Lebo, R. V. (2013). ACMG position statement on prenatal/preconception expanded carrier screening. Genetics in Medicine, 15, 482-483.
4. Haddow, J., & Palomaki, G. (2002). Population based prenatal screening for cystic fibrosis by carrier testing. ACCE: Centers for Disease Control and Prevention (USA).
5. Ioannou, L., Massie, J., Collins, V., McClaren, B., & Delatycki, M. B. (2010). Population-based genetic screening for cystic fibrosis: Attitudes and outcomes. Public Health Genomics, 13, 449-456.
6. Ioannou, L., McClaren, B., Massie, J., Lewis, S., Metcalfe, S., Forrest, L.,.. Delatycki, M. B. (2014). Population-based carrier screening for cystic fibrosis: A systematic review of 23 years of research. Genetics in Medicine, 16, 207-216.
7. Khoury, M. J., McCabe, L. L., & McCabe, E. R. (2003). Population screening in the age of genomic medicine. New England Journal of Medicine, 348, 50-58.
8. Massie, J., Petrou, V., Forbes, R., Curnow, L., Ioannou, L., Dusart, D.,.. Delatycki, M. B. (2009). Population-based carrier screening for cystic fibrosis in Victoria: The first three years experience. Australian and New Zealand Journal of Obstetrics and Gynaecology, 49, 484-489.
9. Radhakrishnan, M., van Gool, K., Hall, J., Delatycki, M., & Massie, J., (2008). Economic evaluation of cystic fibrosis screening: A review of the literature. Health Policy, 85, 133-147.
10. Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Drevinek, P.,.. Elborn, J. S. (2011). A CFTR poten-tiator in patients with cystic fibrosis and the G551D mutation. New England Journal of Medicine, 365, 1663-1672.
11. Rowley, P. T., Loader, S., Kaplan, R. M., (1998). Prenatal screening for cystic fibrosis carriers: An economic evaluation. American Journal of Human Genetics, 63, 1160-1174.
12. Thauvin-Robinet, C., Munck, A., Huet, F., Genin, E., Bellis, G., Gautier, E.,.. Girodon, E. (2009). The very low pen-etrance of cystic fibrosis for the R117H mutation: A reappraisal for genetic counselling and newborn screening. Journal of Medical Genetics, 46, 752-758.
13. Wilson, J., & Junger, G. (1968). The principles and practice of screening for disease (Public Health Paper 34). Geneva: World Health Organization.